Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma

Por Mantopoulos, Dimosthenis, Kendra, Kari L., Letson, Alan D., Cebulla, Colleen M.
Publicado no JAMA Ophthalmol (2015)

Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to Interferon-Alpha

Por Zimmerer, Jason M., Lesinski, Gregory B., Ruppert, Amy S., Radmacher, Michael D., Noble, Carl, Kendra, Kari, Walker, Michael J., Carson, William E.
Publicado em 2008

A Pilot Study of Bevacizumab and Interferon-α2b in Ocular Melanoma

Por Guenterberg, Kristan D., Grignol, Valerie P., Relekar, Kiran V., Varker, Kimberly A., Chen, Helen X., Kendra, Kari L., Olencki, Thomas E., Carson, William E.
Publicado no Am J Clin Oncol (2011)

A Phase II trial of Bevacizumab and High Dose Interferon Alpha-2B in Metastatic Melanoma

Por Grignol, Valerie P., Olencki, Thomas, Relekar, Kiran, Taylor, Cynthia, Kibler, Amanda, Kefauver, Cheryl, Wei, Lai, Walker, Michael J., Chen, Helen X., Kendra, Kari, Carson, William E.
Publicado em 2011

Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib

Por Liebner, David A., Walston, Steven A., Cavaliere, Robert, Powers, Ciaran J., Sauvageau, Eric, Lehman, Norman L., Slone, Hasel Wayne, Xu-Welliver, Meng, Xia, Fen, Kendra, Kari L.
Publicado no Melanoma Res (2014)

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

Por Monk, Paul, Lam, Elaine, Mortazavi, Amir, Kendra, Kari, Lesinski, Gregory B., Mace, Thomas A., Geyer, Susan, Carson, William E., Tahiri, Sanaa, Bhinder, Arvinder, Clinton, Steven K., Olencki, Thomas
Publicado em 2014

Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells

Por Yang, Jennifer, Bill, Matthew A., Young, Gregory S., La Perle, Krista, Landesman, Yosef, Shacham, Sharon, Kauffman, Michael, Senapedis, William, Kashyap, Trinayan, Saint-Martin, Jean-Richard, Kendra, Kari, Lesinski, Gregory B.
Publicado em 2014

Development and Validation of Sensitive Liquid Chromatography/Tandem Mass Spectrometry Methods for Quantification of Bendamustine in Mouse Brain Tissue

Por He, Lei, Grecula, John C., Ling, Yonghua, Enzerra, Michael D., Ammirati, Mario, Kendra, Kari, Cavaliere, Robert, Mayr, Nina, McGregor, John, Olencki, Thomas, Mrozek, Ewa, Matharbootham, Mani, Oluigbo, Chima, Phelps, Mitch A.
Publicado em 2012

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients

Por King, David M., Albertini, Mark R., Schalch, Heidi, Hank, Jacquelyn A., Gan, Jacek, Surfus, Jean, Mahvi, David, Schiller, Joan H., Warner, Thomas, Kim, KyungMann, Eickhoff, Jens, Kendra, Kari, Reisfeld, Ralph, Gillies, Stephen D., Sondel, Paul
Publicado em 2004

A Phase I trial of Bortezomib and Interferon Alfa-2B in Metastatic Melanoma

Por Markowitz, Joseph, Luedke, Eric A., Grignol, Valerie P., Hade, Erinn M., Paul, Bonnie K., Mundy-Bosse, Bethany L., Brooks, Taylor R., Dao, Thao-Vi, Kondalasula, Sri Vidya, Lesinski, Gregory B., Olencki, Thomas, Kendra, Kari L., Carson, William E.
Publicado em 2014

Phase II Trial of Intravenous Administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma

Por Galanis, Evanthia, Markovic, Svetomir N, Suman, Vera J, Nuovo, Gerard J, Vile, Richard G, Kottke, Timothy J, Nevala, Wendy K, Thompson, Michael A, Lewis, Jean E, Rumilla, Kandelaria M, Roulstone, Victoria, Harrington, Kevin, Linette, Gerald P, Maples, William J, Coffey, Matt, Zwiebel, James, Kendra, Kari
Publicado em 2012

MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches

Por Markowitz, Joseph, Abrams, Zachary, Jacob, Naduparambil K, Zhang, Xiaoli, Hassani, John N, Latchana, Nicholas, Wei, Lai, Regan, Kelly E, Brooks, Taylor R, Uppati, Sarvani R, Levine, Kala M, Bekaii-Saab, Tanios, Kendra, Kari L, Lesinski, Gregory B, Howard, J Harrison, Olencki, Thomas, Payne, Philip R, Carson, William E
Publicado no Onco Targets Ther (2016)

Myeloid-derived suppressor cells express Bruton’s tyrosine kinase and can be depleted in tumor bearing hosts by ibrutinib treatment

Por Stiff, Andrew, Trikha, Prashant, Wesolowski, Robert, Kendra, Kari, Hsu, Vincent, Uppati, Sarvani, McMichael, Elizabeth, Duggan, Megan, Campbell, Amanda, Keller, Karen, Landi, Ian, Zhong, Yiming, Dubovsky, Jason, Howard, John Harrison, Yu, Lianbo, Harrington, Bonnie, Old, Matthew, Reiff, Sean, Mace, Thomas, Tridandapani, Susheela, Muthusamy, Natarajan, Caligiuri, Michael A., Byrd, John C., Carson, William E.
Publicado no Cancer Res (2016)

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Por Ribas, Antoni, Kefford, Richard, Marshall, Margaret A., Punt, Cornelis J.A., Haanen, John B., Marmol, Maribel, Garbe, Claus, Gogas, Helen, Schachter, Jacob, Linette, Gerald, Lorigan, Paul, Kendra, Kari L., Maio, Michele, Trefzer, Uwe, Smylie, Michael, McArthur, Grant A., Dreno, Brigitte, Nathan, Paul D., Mackiewicz, Jacek, Kirkwood, John M., Gomez-Navarro, Jesus, Huang, Bo, Pavlov, Dmitri, Hauschild, Axel
Publicado no J Clin Oncol (2013)

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Por Schwartzentruber, Douglas J., Lawson, David H., Richards, Jon M., Conry, Robert M., Miller, Donald M., Treisman, Jonathan, Gailani, Fawaz, Riley, Lee, Conlon, Kevin, Pockaj, Barbara, Kendra, Kari L., White, Richard L., Gonzalez, Rene, Kuzel, Timothy M., Curti, Brendan, Leming, Phillip D., Whitman, Eric D., Balkissoon, Jai, Reintgen, Douglas S., Kaufman, Howard, Marincola, Francesco M., Merino, Maria J., Rosenberg, Steven A., Choyke, Peter, Vena, Don, Hwu, Patrick
Publicado em 2011